Dubai, U.A.E, June 10, 2021 /PRNewswire/ The global advanced empty capsule market sales are set to grow at over 8% CAGR during the forecast period of 2021 and 2031, estimates ESOMAR-certified
Citing a National Security Risk, Lyfe Group™ White Paper Outlines the Urgent Need to Deglobalize Pharmaceutical Production
Reliance on China and India for medicines called a disaster waiting to happen
News provided by
Share this article
Share this article
DANIA BEACH, Fla., May 20, 2021 /PRNewswire/ Citing a threat to national security, Lyfe Group™ a well-respected global manufacturer of pharmaceutical products, has announced the publication of a white paper calling for U.S. policy makers to urgently take action to decrease the reliance of the U.S. supply of medications on countries such as China and India by deglobalizing the production of active pharmaceutical ingredients (APIs) and pharmaceuticals.
CapsCanada Launches Liquid-Filled Hard Capsule Manufacturing Service in North America biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.
Share this article
DANIA BEACH, Fla., March 10, 2021 /PRNewswire/ CapsCanada, a Lyfe Group
™ company and leader in capsule technology for over three decades, is pleased to announce the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada s objective is to support the entire manufacturing process, from formulation and development through full-scale production. In creating this service CapsCanada partnered with one of the leading manufacturers of generic and branded drugs in Canada. Production will be done at a dedicated Health Canada-approved facility in Canada that has a full analytical lab, licensing for controlled drugs and substances including narcotics and a choice of blister or bottle packaging. The facility is also US FDA approved and cGMP compliant for the manufacture and testing of injectables and is currently awaiting US FDA approval for the manufacture and testing of solid oral dosage forms.